AIDR logo

Rocket Doctor AI Inc. Stock Price

CNSX:AIDR Community·CA$54.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

AIDR Share Price Performance

CA$0.65
-0.07 (-9.72%)
CA$0.65
-0.07 (-9.72%)
Price CA$0.65

AIDR Community Narratives

There are no narratives available yet.

Recent AIDR News & Updates

Rocket Doctor AI Inc. Key Details

CA$38.1k

Revenue

CA$13.9k

Cost of Revenue

CA$24.2k

Gross Profit

CA$2.0m

Other Expenses

-CA$2.0m

Earnings

Last Reported Earnings
Sep 30, 2023
Next Reporting Earnings
n/a
Earnings per share (EPS)
0
Gross Margin
0%
Net Profit Margin
0%
Debt/Equity Ratio
0%

Rocket Doctor AI Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

About AIDR

Founded
2018
Employees
n/a
CEO
Essam Hamza
WebsiteView website
www.treatment.com

Rocket Doctor AI Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Canadian Market Performance

  • 7 Days: 1.3%
  • 3 Months: 11.0%
  • 1 Year: 22.5%
  • Year to Date: 20.2%
The market is up 1.3% over the last week, with the Materials sector leading the way, up 3.0%. The market is up 22% over the last 12 months. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›